EFFECTS OF CHOLECYSTOKININ-OCTAPEPTIDE AND BC-264, A POTENT AND SELECTIVE CCK-B AGONIST ON ASPARTATE AND GLUTAMATE RELEASE FROM RAT HIPPOCAMPAL SLICES

Citation
M. Migaud et al., EFFECTS OF CHOLECYSTOKININ-OCTAPEPTIDE AND BC-264, A POTENT AND SELECTIVE CCK-B AGONIST ON ASPARTATE AND GLUTAMATE RELEASE FROM RAT HIPPOCAMPAL SLICES, Neuropharmacology, 33(6), 1994, pp. 737-743
Citations number
47
Categorie Soggetti
Pharmacology & Pharmacy",Neurosciences
Journal title
ISSN journal
00283908
Volume
33
Issue
6
Year of publication
1994
Pages
737 - 743
Database
ISI
SICI code
0028-3908(1994)33:6<737:EOCABA>2.0.ZU;2-D
Abstract
In rat hippocampal slices, BC 264 (0.1-1 mu M), a highly potent and se lective CCK-B agonist, was found to increase basal release of endogeno us glutamate and aspartate but not that of GABA. The natural peptide, cholecystokinin octapeptide (CCK8) at 1 mu M, induced the same effect. The selective CCK-B receptor antagonist, L-365,260, completely revers ed these responses, confirming that they are related to CCK-B receptor activation. In the absence of extracellular Ca2+, the increase in exc itatory amino acid release was completely abolished. In contrast to th e basal release, the potassium evoked release of aspartate and glutama te was not modified by BC 264.